How many drugs treat Thromboembolic disorder?

Drug Landscape tracks 2 marketed treatments for Thromboembolic disorder (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/thromboembolic-disorder.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Thromboembolic disorder — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thromboembolic disorder (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Thromboembolic disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Coumadin	warfarin	Generic (originally Wisconsin Alumni Research Foundation)	Vitamin K antagonist (anticoagulant)	Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7		1954-01-01
Dicuman	dicoumarol	AbbVie	dicoumarol	NAD(P)H dehydrogenase [quinone] 1		1944-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Thromboembolic disorder
AbbVie · 1 drug in Thromboembolic disorder
Generic (originally Wisconsin Alumni Research Foundation) · 1 drug in Thromboembolic disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Thromboembolic disorder:

Cite this brief

Drug Landscape (2026). Thromboembolic disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/thromboembolic-disorder. Accessed 2026-06-10.

Thromboembolic disorder full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing